GSK logo linking to the homepage
COVID-19 Our response to COVID-19
COVID-19
Behind the science Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs
Behind the science
Where we operate
Global website
Contact us Search Menu
  • About us
    Close menu
    About us

    We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

    Visit this section

    Back About us Visit this section
    • Pharmaceuticals
    • Vaccines
    • Consumer Healthcare
    • Corporate Executive Team
    • Board of Directors
    • Our history
      Back Our history Visit this section
      • Innovative entrepreneurs: 1715 – 1891
      • Going global: 1892 – 1918
      • Building brands: 1919 – 1949
      • Creating the GSK of today: 1950 – 1999
      • GSK today: 2000 – present
      • GSK heritage archives
    • Governance
      Back Governance Visit this section
      • Board Committees
      • Other committees
      • Shareholders
      • Sarbanes-Oxley Act 2002
      • Global Ethics and Compliance
    • Policies, codes and standards
    • Key facts
    • Comic Relief partnership
      Back Comic Relief partnership Visit this section
      • Sierra Leone
      • Ghana
      • Mozambique
      • Tanzania
      • Greater Mekong Subregion
      • Johari, mother of four
      • Leonard, father, farmer and assistant
      • Nsaje, teacher
      • Johari, mother of two
      • Jacob, Tanzania Communication and Development Centre
      • Patrick, malaria patient
      • The race against malaria: handing the baton to the next generation
    • Save the Children partnership
      Back Save the Children partnership Visit this section
      • Overview
      • Meet the children
      • Trek for Kids
      • Meet Baby Mckline: a special delivery
      • The app that could save lives
      • A new response to humanitarian crises
      • Giving mothers and babies a healthier start
    • Smile Train partnership
    About us

    We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

  • Products
    Close menu
    Products

    We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare

    Visit this section

    Back Products Visit this section
    • Our prescription medicines
    • Our vaccines
    • Our consumer healthcare products
    • ViiV Healthcare
    • Stiefel dermatology
    Our consumer healthcare products

    When you experience discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products are here to help you enjoy life to the full again.

  • Careers
    Close menu
    Careers

    We are a global company delivering billions of healthcare products a year. Choose your path.

    Visit this section

    Back Careers Visit this section
    • Search jobs
    • COVID-19
    • Experienced professionals
      Back Experienced professionals Visit this section
      • Business operations
      • Engineering
      • Manufacturing and supply
      • Marketing and communications
      • Research and development
      • Sales
    • Physicians
    • Apprentices, students and graduates
      Back Apprentices, students and graduates Visit this section
      • School students - what next
      • Apprentice programmes
      • Work experience, placements and internships
      • Future Leaders graduate programme
      • Direct entry
    • Postgraduate opportunities
      Back Postgraduate opportunities Visit this section
      • Esprit commercial (Pharmaceuticals)
      • Esprit commercial (Consumer Healthcare)
      • Esprit finance
      • MBA internships
      • Esprit R&D development programme
      • Postdoctoral R&D
      • Postdoctoral Immunology Catalyst
    • Meet our people
    • Culture and values
    • Career benefits
    • Tips for applying
    • Warning against fraudulent internet recruitment activities
    Meet our people

    Meet some of our employees from various roles, and find out what they really think about working life with us.

  • Investors
    Close menu
    Investors

    Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting

    Visit this section

    Back Investors Visit this section
    • Shareholder information
      Back Shareholder information Visit this section
      • Dividend calculator (GBP)
      • Dividend calculator (USD)
      • Dividend calendar
      • Manage your shares
      • Annual General Meeting
      • General Meeting
      • Corporate sponsored nominee service
      • Asset Reunification – ProSearch
      • FAQs
      • Share scam alert
      • Annual Governance Meeting
      • Privacy Notice for Ordinary shareholders
    • Quarterly results
    • Corporate reporting
      Back Corporate reporting Visit this section
      • Annual Report 2019
      • Corporate reporting archive
    • Share price analysis
      Back Share price analysis Visit this section
      • GSK share price
      • Share price calculator (GBP)
      • Share price calculator (USD)
    • Financial calendar
    • Analyst consensus
    • Debt investors
    • Stock exchange announcements
      Back Stock exchange announcements Visit this section
      • London (RNS)
      • London (RNS) inside information
      • New York (SEC)
      • Sign up for announcements
    • About GSK
    • Speeches & presentations
    • Investors contact details
    • Agreement to acquire TESARO
    • Consumer Healthcare Joint Venture
    Iain Mackay Quarterly results

    Discover our latest financial performance announcement and search for historical quarterly results materials

  • Media
    Close menu
    Media

    Explore the latest news, different ways to stay in touch and available useful resources

    Visit this section

    Back Media Visit this section
    • Press releases
    • Resource centre
      Back Resource centre Visit this section
      • Our approach to Brexit
      • Pharmaceuticals resources
      • GSK actions to support the global response to COVID-19
    • Social media
      Back Social media Visit this section
      • Facebook
    • RSS feeds
    • Image and video library
    • Media contact details
    Employees walking across a bridge at GSK House, UK Press releases

    Keep up to date with our news and recent announcements

  • Research and development
    Close menu
    Research and development

    Science can improve health and well-being in so many ways, from the development of everyday healthcare products to medicines and vaccines.

    Visit this section

    Back Research and development Visit this section
    • Our approach to R&D
    • Our pipeline
    • Research
      Back Research Visit this section
      • How we research new medicines
      • How we research new vaccines
    • Development
      Back Development Visit this section
      • Our focus areas
      • How we develop new medicines
      • How we develop new vaccines
    • Partnerships
      Back Partnerships Visit this section
      • Our areas of interest
      • Our approach to partnering
      • Supported studies
      • Business development
      • Academic collaborations
      • Venture funds
      • Contact us/submit an idea
    • Trials in people
      Back Trials in people Visit this section
      • GSK Study Register and patient level data
      • Clinical trial phases
      • Become a clinical research volunteer
      • Data transparency
      • Compassionate use (Expanded access)
    • Our use of animals
      Back Our use of animals Visit this section
      • The 3Rs in medicine research
      • Use of non-human primates
      • Frequently asked questions
    • Consumer Healthcare research
    • R&D locations
  • Responsibility
    Close menu
    Responsibility

    Responsible business is how we do business. Our purpose is to help people to do more, feel better, live longer.

    Visit this section

    Back Responsibility Visit this section
    • Improving health globally
      Back Improving health globally Visit this section
      • Using our science for global health
      • Preparing for future disease threats
      • Pricing and access strategies
      • Prevention, awareness and infrastructure
      • “Pull” the Science: 2020 Antimicrobial Resistance Benchmark
    • Operating responsibly
      Back Operating responsibly Visit this section
      • Ethics and values
      • Patient safety and reliable supply
      • Research practices
      • Engaging with healthcare professionals
      • Sales representative incentive programme
      • Public policy and patient advocacy
      • Human rights and modern slavery
    • Our people
      Back Our people Visit this section
      • Inclusion and diversity
      • Employee engagement
      • Health and wellbeing
      • Learning and development
    • Environment
      Back Environment Visit this section
      • Carbon
      • Water
      • Waste
      • Environmental stewardship
    • Responsibility reports & data
      Back Responsibility reports & data Visit this section
      • Reporting archive and resources
      • Charitable grants
      • Trade association memberships
      • Patient group funding
    Pulse Report Thumb Improving health globally

    Millions of people live with unmet healthcare needs. We want to help change this, using our scientific expertise, our partnerships and our global reach.

×
Where we operate
You are currently visiting our global website.
  • Global https://www.gsk.com
  • Africa
    • Algeria (EN)
    • Kenya (EN)
    • Morocco (EN)
    • Nigeria (EN)
    • South Africa (EN)
    • Tunisia (EN)
  • Asia & the Middle East
    • Bangladesh (EN)
    • Cambodia (EN)
    • China (Mainland) (ZH/EN)
    • Egypt (EN/AR)
    • Hong Kong and Macau (EN/ZH)
    • India (EN)
    • Indonesia (EN)
    • Israel (EN)
    • Japan (JP)
    • Kazakhstan (RU)
    • Korea (KO)
    • Malaysia (EN)
    • Myanmar (EN)
    • Pakistan (EN/UR)
    • Philippines (EN)
    • Saudi Arabia (EN)
    • Singapore (EN)
    • Sri Lanka (EN)
    • Taiwan (ZH)
    • Thailand (EN)
    • Turkey (TR)
    • United Arab Emirates (EN)
    • Vietnam (EN)
  • Australasia
    • Australia (EN)
    • New Zealand (EN)
  • Europe
    • Albania (EN)
    • Austria (DE)
    • Belarus (EN)
    • Belgium (FR/NL/EN)
    • Bosnia and Herzegovina (EN)
    • Bulgaria (BG)
    • Croatia (EN)
    • Cyprus (EN)
    • Czech Republic (CS)
    • Denmark (DA)
    • Estonia (EN)
    • Finland (FI)
    • France (FR)
    • Germany (DE)
    • Greece (EL)
    • Hungary (HU)
    • Ireland (EN)
    • Italy (IT)
    • Latvia (EN)
    • Lithuania (EN)
    • Luxembourg (FR/NL/EN)
    • Macedonia (EN)
    • Malta (EN)
    • Netherlands (NL)
    • Norway (NB)
    • Poland (PL)
    • Portugal (PT)
    • Romania (RO)
    • Russia (RU)
    • Serbia (SR)
    • Slovakia (SK)
    • Slovenia (SL)
    • Spain (ES)
    • Sweden (SV)
    • Switzerland (DE/FR)
    • Ukraine (UK)
    • United Kingdom (EN)
  • North America
    • Canada (EN/FR)
    • Mexico (EN)
    • United States (EN)
  • South & Central America
    • Argentina (ES)
    • Brazil (PT)
    • Caribbean Islands (EN)
    • Chile (EN)
    • Colombia (EN/ES)
    • Costa Rica (EN)
    • Dominican Republic (EN)
    • Ecuador (EN)
    • El Salvador (EN)
    • Guatemala (EN)
    • Honduras (EN)
    • Jamaica (EN)
    • Panama (EN/ES)
    • Peru (EN)
    • Trinidad & Tobago (EN)
    • Uruguay (EN)
    • Venezuela (EN)
  2. Investors
  3. Stock exchange announcements
  4. London (RNS)

London (RNS)

Other key information

  • A pen on a document

    London (RNS) inside information

    London Stock Exchange announcements containing inside information
  • hand-clipboard-trials

    New York (SEC)

    All New York Stock Exchange announcements and filings
  • Iain Mackay

    Quarterly results

    Discover our latest financial performance announcement and search for historical quarterly results materials
  • Employees walking across a bridge at GSK House, UK

    Press releases

    Keep up to date with our news and recent announcements
GSK
  • RSS

  • Quick links

  • COVID-19 response
  • Behind the science
  • About us
  • Products
  • Careers
  • Investors
  • Media
  • Research and development
  • Responsibility

  • Legal

  • Terms of use
  • Cookie policy
  • Global website privacy notice
  • Modern Slavery Act statement 2019PDF - 214.5KB

  • Accessibility

  • Sitemap
  • Accessibility

  • Contact us

  • Contact us
  • Headquarters
  • Worldwide directory
  • Partnerships
  • Report a possible side effect
  • Privacy contact information

  • Business to business

  • Supplier website
  • Business to business

© 2001-2020 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.
GlaxoSmithKline plc. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.